 | • レポートコード：QY20ST-02980 • 出版社/出版日：QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医療機器・消耗品 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界のパクリタキセル溶出ステント市場について種類別（金属ステント、ポリマーステント、その他）、用途別（冠動脈疾患、臨床、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・パクリタキセル溶出ステント市場の概要 ・世界の主要地域別パクリタキセル溶出ステント市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のパクリタキセル溶出ステント市場規模2015-2026：種類別（金属ステント、ポリマーステント、その他） ・世界のパクリタキセル溶出ステント市場規模2015-2026：用途別（冠動脈疾患、臨床、その他） ・パクリタキセル溶出ステントの北米市場規模2015-2020 ・パクリタキセル溶出ステントのヨーロッパ市場規模2015-2020 ・パクリタキセル溶出ステントの中国市場規模2015-2020 ・パクリタキセル溶出ステントの日本市場規模2015-2020 ・パクリタキセル溶出ステントの東南アジア市場規模2015-2020 ・パクリタキセル溶出ステントのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・パクリタキセル溶出ステントの製造コスト分析 ・販売チャネル、流通業者、顧客 ・パクリタキセル溶出ステントの市場動向・機会・課題 ・調査の結論 |
Paclitaxel-eluting stent is used to prevent cell proliferation and avoid fibrosis that could block the stented artery with the clots in a process called restenosis. The stents are scaffolds that can be placed inside diseased or narrowed coronary arteries to release a drug (at a slow speed) to inhibit cell proliferation.
Market Analysis and Insights: Global Paclitaxel-eluting Stent Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Paclitaxel-eluting Stent market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Paclitaxel-eluting Stent industry.
Based on our recent survey, we have several different scenarios about the Paclitaxel-eluting Stent YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Paclitaxel-eluting Stent will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Paclitaxel-eluting Stent Scope and Market Size
The global Paclitaxel-eluting Stent market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Paclitaxel-eluting Stent market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Paclitaxel-eluting Stent market is segmented into
Metal Stent
Polymer Stent
Others
Segment by Application, the Paclitaxel-eluting Stent market is segmented into
Coronary Heart Disease
Clinical
Others
The Paclitaxel-eluting Stent market is analysed and market size information is provided by regions (countries). Segment by Application, the Paclitaxel-eluting Stent market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Paclitaxel-eluting Stent Market Share Analysis
Paclitaxel-eluting Stent market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Paclitaxel-eluting Stent business, the date to enter into the Paclitaxel-eluting Stent market, Paclitaxel-eluting Stent product introduction, recent developments, etc.
The major vendors covered:
B.Braun Melsengen AG
Biosensors
Biotronik
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
Terumo Medical
Orbusneich
1 Paclitaxel-eluting Stent Market Overview
1.1 Paclitaxel-eluting Stent Product Scope
1.2 Paclitaxel-eluting Stent Segment by Type
1.2.1 Global Paclitaxel-eluting Stent Sales by Type (2020-2026)
1.2.2 Metal Stent
1.2.3 Polymer Stent
1.2.4 Others
1.3 Paclitaxel-eluting Stent Segment by Application
1.3.1 Global Paclitaxel-eluting Stent Sales Comparison by Application (2020-2026)
1.3.2 Coronary Heart Disease
1.3.3 Clinical
1.3.4 Others
1.4 Paclitaxel-eluting Stent Market Estimates and Forecasts (2015-2026)
1.4.1 Global Paclitaxel-eluting Stent Sales Growth Rate (2015-2026)
1.4.2 Global Paclitaxel-eluting Stent Revenue and Growth Rate (2015-2026)
1.4.3 Global Paclitaxel-eluting Stent Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Paclitaxel-eluting Stent Industry Impact
1.5.1 How the Covid-19 is Affecting the Paclitaxel-eluting Stent Industry
1.5.1.1 Paclitaxel-eluting Stent Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Paclitaxel-eluting Stent Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Paclitaxel-eluting Stent Players to Combat Covid-19 Impact
2 Paclitaxel-eluting Stent Estimate and Forecast by Region
2.1 Global Paclitaxel-eluting Stent Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Paclitaxel-eluting Stent Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Paclitaxel-eluting Stent Sales Market Share by Region (2015-2020)
2.2.2 Global Paclitaxel-eluting Stent Revenue Market Share by Region (2015-2020)
2.3 Global Paclitaxel-eluting Stent Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Paclitaxel-eluting Stent Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Paclitaxel-eluting Stent Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Paclitaxel-eluting Stent Estimates and Projections (2015-2026)
2.4.2 Europe Paclitaxel-eluting Stent Estimates and Projections (2015-2026)
2.4.3 China Paclitaxel-eluting Stent Estimates and Projections (2015-2026)
2.4.4 Japan Paclitaxel-eluting Stent Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Paclitaxel-eluting Stent Estimates and Projections (2015-2026)
2.4.6 India Paclitaxel-eluting Stent Estimates and Projections (2015-2026)
3 Global Paclitaxel-eluting Stent Competition Landscape by Players
3.1 Global Top Paclitaxel-eluting Stent Players by Sales (2015-2020)
3.2 Global Top Paclitaxel-eluting Stent Players by Revenue (2015-2020)
3.3 Global Paclitaxel-eluting Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paclitaxel-eluting Stent as of 2019)
3.4 Global Paclitaxel-eluting Stent Average Price by Company (2015-2020)
3.5 Manufacturers Paclitaxel-eluting Stent Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Paclitaxel-eluting Stent Players (Opinion Leaders)
4 Global Paclitaxel-eluting Stent Market Size by Type
4.1 Global Paclitaxel-eluting Stent Historic Market Review by Type (2015-2020)
4.1.1 Global Paclitaxel-eluting Stent Sales Market Share by Type (2015-2020)
4.1.2 Global Paclitaxel-eluting Stent Revenue Market Share by Type (2015-2020)
4.1.3 Global Paclitaxel-eluting Stent Price by Type (2014-2020)
4.2 Global Paclitaxel-eluting Stent Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Paclitaxel-eluting Stent Sales Forecast by Type (2021-2026)
4.2.2 Global Paclitaxel-eluting Stent Revenue Forecast by Type (2021-2026)
4.2.3 Global Paclitaxel-eluting Stent Price Forecast by Type (2021-2026)
5 Global Paclitaxel-eluting Stent Market Size by Application
5.1 Global Paclitaxel-eluting Stent Historic Market Review by Application (2015-2020)
5.1.1 Global Paclitaxel-eluting Stent Sales Market Share by Application (2015-2020)
5.1.2 Global Paclitaxel-eluting Stent Revenue Market Share by Application (2015-2020)
5.1.3 Global Paclitaxel-eluting Stent Price by Application (2015-2020)
5.2 Global Paclitaxel-eluting Stent Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Paclitaxel-eluting Stent Sales Forecast by Application (2021-2026)
5.2.2 Global Paclitaxel-eluting Stent Revenue Forecast by Application (2021-2026)
5.2.3 Global Paclitaxel-eluting Stent Price Forecast by Application (2021-2026)
3 North America Paclitaxel-eluting Stent Market Facts & Figures
3.2 North America Paclitaxel-eluting Stent Sales Market Share by Company (2015-2020)
3.3 North America Paclitaxel-eluting Stent Sales Market Share by Type (2015-2020)
3.4 North America Paclitaxel-eluting Stent Sales Market Share by Application (2015-2020)
4 Europe Paclitaxel-eluting Stent Market Facts & Figures
4.2 Europe Paclitaxel-eluting Stent Sales Market Share by Company (2015-2020)
4.3 Europe Paclitaxel-eluting Stent Sales Market Share by Type (2015-2020)
4.4 Europe Paclitaxel-eluting Stent Sales Market Share by Application (2015-2020)
5 China Paclitaxel-eluting Stent Market Facts & Figures
5.2 China Paclitaxel-eluting Stent Sales Market Share by Company (2015-2020)
5.3 China Paclitaxel-eluting Stent Sales Market Share by Type (2015-2020)
5.4 China Paclitaxel-eluting Stent Sales Market Share by Application (2015-2020)
6 Japan Paclitaxel-eluting Stent Market Facts & Figures
6.2 Japan Paclitaxel-eluting Stent Sales Market Share by Company (2015-2020)
6.3 Japan Paclitaxel-eluting Stent Sales Market Share by Type (2015-2020)
6.4 Japan Paclitaxel-eluting Stent Sales Market Share by Application (2015-2020)
7 Southeast Asia Paclitaxel-eluting Stent Market Facts & Figures
7.2 Southeast Asia Paclitaxel-eluting Stent Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Paclitaxel-eluting Stent Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Paclitaxel-eluting Stent Sales Market Share by Application (2015-2020)
8 India Paclitaxel-eluting Stent Market Facts & Figures
8.2 India Paclitaxel-eluting Stent Sales Market Share by Company (2015-2020)
8.3 India Paclitaxel-eluting Stent Sales Market Share by Type (2015-2020)
8.4 India Paclitaxel-eluting Stent Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Paclitaxel-eluting Stent Business
12.1 B.Braun Melsengen AG
12.1.1 B.Braun Melsengen AG Paclitaxel-eluting Stent Corporation Information
12.1.2 B.Braun Melsengen AG Paclitaxel-eluting Stent Business Overview and Total Revenue
12.1.3 B.Braun Melsengen AG Paclitaxel-eluting Stent Sales, Revenue and Gross Margin (2015-2020)
12.1.4 B.Braun Melsengen AG Paclitaxel-eluting Stent Products Offered
12.1.5 B.Braun Melsengen AG Recent Development
12.2 Biosensors
12.2.1 Biosensors Paclitaxel-eluting Stent Corporation Information
12.2.2 Biosensors Paclitaxel-eluting Stent Business Overview and Total Revenue
12.2.3 Biosensors Paclitaxel-eluting Stent Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Biosensors Paclitaxel-eluting Stent Products Offered
12.2.5 Biosensors Recent Development
12.3 Biotronik
12.3.1 Biotronik Paclitaxel-eluting Stent Corporation Information
12.3.2 Biotronik Paclitaxel-eluting Stent Business Overview and Total Revenue
12.3.3 Biotronik Paclitaxel-eluting Stent Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Biotronik Paclitaxel-eluting Stent Products Offered
12.3.5 Biotronik Recent Development
12.4 Blue Medical
12.4.1 Blue Medical Paclitaxel-eluting Stent Corporation Information
12.4.2 Blue Medical Paclitaxel-eluting Stent Business Overview and Total Revenue
12.4.3 Blue Medical Paclitaxel-eluting Stent Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Blue Medical Paclitaxel-eluting Stent Products Offered
12.4.5 Blue Medical Recent Development
12.5 Boston Scientific
12.5.1 Boston Scientific Paclitaxel-eluting Stent Corporation Information
12.5.2 Boston Scientific Paclitaxel-eluting Stent Business Overview and Total Revenue
12.5.3 Boston Scientific Paclitaxel-eluting Stent Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Boston Scientific Paclitaxel-eluting Stent Products Offered
12.5.5 Boston Scientific Recent Development
12.6 DISA Vascular
12.6.1 DISA Vascular Paclitaxel-eluting Stent Corporation Information
12.6.2 DISA Vascular Paclitaxel-eluting Stent Business Overview and Total Revenue
12.6.3 DISA Vascular Paclitaxel-eluting Stent Sales, Revenue and Gross Margin (2015-2020)
12.6.4 DISA Vascular Paclitaxel-eluting Stent Products Offered
12.6.5 DISA Vascular Recent Development
12.7 Essen
12.7.1 Essen Paclitaxel-eluting Stent Corporation Information
12.7.2 Essen Paclitaxel-eluting Stent Business Overview and Total Revenue
12.7.3 Essen Paclitaxel-eluting Stent Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Essen Paclitaxel-eluting Stent Products Offered
12.7.5 Essen Recent Development
12.8 Medtronic Vascular
12.8.1 Medtronic Vascular Paclitaxel-eluting Stent Corporation Information
12.8.2 Medtronic Vascular Paclitaxel-eluting Stent Business Overview and Total Revenue
12.8.3 Medtronic Vascular Paclitaxel-eluting Stent Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Medtronic Vascular Paclitaxel-eluting Stent Products Offered
12.8.5 Medtronic Vascular Recent Development
12.9 MicroPort Medical
12.9.1 MicroPort Medical Paclitaxel-eluting Stent Corporation Information
12.9.2 MicroPort Medical Paclitaxel-eluting Stent Business Overview and Total Revenue
12.9.3 MicroPort Medical Paclitaxel-eluting Stent Sales, Revenue and Gross Margin (2015-2020)
12.9.4 MicroPort Medical Paclitaxel-eluting Stent Products Offered
12.9.5 MicroPort Medical Recent Development
12.10 Terumo Medical
12.10.1 Terumo Medical Paclitaxel-eluting Stent Corporation Information
12.10.2 Terumo Medical Paclitaxel-eluting Stent Business Overview and Total Revenue
12.10.3 Terumo Medical Paclitaxel-eluting Stent Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Terumo Medical Paclitaxel-eluting Stent Products Offered
12.10.5 Terumo Medical Recent Development
12.11 Orbusneich
12.11.1 Orbusneich Paclitaxel-eluting Stent Corporation Information
12.11.2 Orbusneich Paclitaxel-eluting Stent Business Overview and Total Revenue
12.11.3 Orbusneich Paclitaxel-eluting Stent Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Orbusneich Paclitaxel-eluting Stent Products Offered
12.11.5 Orbusneich Recent Development
13 Paclitaxel-eluting Stent Manufacturing Cost Analysis
13.1 Paclitaxel-eluting Stent Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Paclitaxel-eluting Stent
13.4 Paclitaxel-eluting Stent Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Paclitaxel-eluting Stent Distributors List
14.3 Paclitaxel-eluting Stent Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Paclitaxel-eluting Stent Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Paclitaxel-eluting Stent Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Paclitaxel-eluting Stent Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Paclitaxel-eluting Stent Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Paclitaxel-eluting Stent Players to Combat Covid-19 Impact
Table 8. Global Market Paclitaxel-eluting Stent Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Paclitaxel-eluting Stent Sales (K Units) by Region (2015-2020)
Table 10. Global Paclitaxel-eluting Stent Sales Market Share by Region (2015-2020)
Table 11. Global Paclitaxel-eluting Stent Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Paclitaxel-eluting Stent Revenue Share by Region (2015-2020)
Table 13. Global Paclitaxel-eluting Stent Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Paclitaxel-eluting Stent Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Paclitaxel-eluting Stent Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Paclitaxel-eluting Stent Revenue Share Forecast by Region (2021-2026)
Table 17. Global Paclitaxel-eluting Stent (K Units) of Key Companies (2015-2020)
Table 18. Global Paclitaxel-eluting Stent Sales Share by Company (2015-2020)
Table 19. Global Paclitaxel-eluting Stent Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Paclitaxel-eluting Stent Revenue Share by Company (2015-2020)
Table 21. Global Paclitaxel-eluting Stent by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paclitaxel-eluting Stent as of 2019)
Table 22. Global Paclitaxel-eluting Stent Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Paclitaxel-eluting Stent Manufacturing Sites and Area Served
Table 24. Manufacturers Paclitaxel-eluting Stent Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Paclitaxel-eluting Stent Players
Table 27. Global Paclitaxel-eluting Stent Sales (K Units) by Type (2015-2020)
Table 28. Global Paclitaxel-eluting Stent Sales Share by Type (2015-2020)
Table 29. Global Paclitaxel-eluting Stent Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Paclitaxel-eluting Stent Price (K Units) by Type (2015-2020)
Table 31. Global Paclitaxel-eluting Stent Sales Share by Type (2021-2026)
Table 32. Global Paclitaxel-eluting Stent Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Paclitaxel-eluting Stent Revenue Share by Type (2021-2026)
Table 34. Global Paclitaxel-eluting Stent Price (K Units) by Type (2021-2026)
Table 35. Global Paclitaxel-eluting Stent Sales (K Units) by Application (2015-2020)
Table 36. Global Paclitaxel-eluting Stent Sales Share by Application (2015-2020)
Table 37. Global Paclitaxel-eluting Stent Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Paclitaxel-eluting Stent Price (K Units) by Application (2015-2020)
Table 39. Global Paclitaxel-eluting Stent Sales (K Units) by Application (2021-2026)
Table 40. Global Paclitaxel-eluting Stent Sales Share by Application (2021-2026)
Table 41. Global Paclitaxel-eluting Stent Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Paclitaxel-eluting Stent Revenue Share by Application (2021-2026)
Table 43. Global Paclitaxel-eluting Stent Price (K Units) by Application (2021-2026)
Table 44. United States Paclitaxel-eluting Stent Sales (K Units) by Company (2015-2020)
Table 45. United States Paclitaxel-eluting Stent Sales Market Share by Company (2015-2020)
Table 46. United States Paclitaxel-eluting Stent Sales (K Units) by Type (2015-2020)
Table 47. United States Paclitaxel-eluting Stent Sales Market Share by Type (2015-2020)
Table 48. United States Paclitaxel-eluting Stent Sales (K Units) by Application (2015-2020)
Table 49. United States Paclitaxel-eluting Stent Sales Market Share by Application (2015-2020)
Table 50. Europe Paclitaxel-eluting Stent Sales (K Units) by Company (2015-2020)
Table 51. Europe Paclitaxel-eluting Stent Sales Market Share by Company (2015-2020)
Table 52. Europe Paclitaxel-eluting Stent Sales (K Units) by Type (2015-2020)
Table 53. Europe Paclitaxel-eluting Stent Sales Market Share by Type (2015-2020)
Table 54. Europe Paclitaxel-eluting Stent Sales (K Units) by Application (2015-2020)
Table 55. Europe Paclitaxel-eluting Stent Sales Market Share by Type (2015-2020)
Table 56. China Paclitaxel-eluting Stent Sales (K Units) by Company (2015-2020)
Table 57. China Paclitaxel-eluting Stent Sales Market Share by Company (2015-2020)
Table 58. China Paclitaxel-eluting Stent Sales (K Units) by Type (2015-2020)
Table 59. China Paclitaxel-eluting Stent Sales Market Share by Type (2015-2020)
Table 60. China Paclitaxel-eluting Stent Sales (K Units) by Application (2015-2020)
Table 61. China Paclitaxel-eluting Stent Sales Market Share by Application (2015-2020)
Table 62. Japan Paclitaxel-eluting Stent Sales (K Units) by Company (2015-2020)
Table 63. Japan Paclitaxel-eluting Stent Sales Market Share by Company (2015-2020)
Table 64. Japan Paclitaxel-eluting Stent Sales (K Units) by Type (2015-2020)
Table 65. Japan Paclitaxel-eluting Stent Sales Market Share by Type (2015-2020)
Table 66. Japan Paclitaxel-eluting Stent Sales (K Units) by Application (2015-2020)
Table 67. Japan Paclitaxel-eluting Stent Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Paclitaxel-eluting Stent Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Paclitaxel-eluting Stent Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Paclitaxel-eluting Stent Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Paclitaxel-eluting Stent Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Paclitaxel-eluting Stent Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Paclitaxel-eluting Stent Sales Market Share by Application (2015-2020)
Table 74. India Paclitaxel-eluting Stent Sales (K Units) by Company (2015-2020)
Table 75. India Paclitaxel-eluting Stent Sales Market Share by Company (2015-2020)
Table 76. India Paclitaxel-eluting Stent Sales (K Units) by Type (2015-2020)
Table 77. India Paclitaxel-eluting Stent Sales Market Share by Type (2015-2020)
Table 78. India Paclitaxel-eluting Stent Sales (K Units) by Application (2015-2020)
Table 79. India Paclitaxel-eluting Stent Sales Market Share by Application (2015-2020)
Table 80. B.Braun Melsengen AG Corporation Information
Table 81. B.Braun Melsengen AG Description and Business Overview
Table 82. B.Braun Melsengen AG Paclitaxel-eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. B.Braun Melsengen AG Paclitaxel-eluting Stent Product
Table 84. B.Braun Melsengen AG Recent Development
Table 85. Biosensors Corporation Information
Table 86. Biosensors Description and Business Overview
Table 87. Biosensors Paclitaxel-eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Biosensors Paclitaxel-eluting Stent Product
Table 89. Biosensors Recent Development
Table 90. Biotronik Corporation Information
Table 91. Biotronik Description and Business Overview
Table 92. Biotronik Paclitaxel-eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Biotronik Paclitaxel-eluting Stent Product
Table 94. Biotronik Recent Development
Table 95. Blue Medical Corporation Information
Table 96. Blue Medical Description and Business Overview
Table 97. Blue Medical Paclitaxel-eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Blue Medical Paclitaxel-eluting Stent Product
Table 99. Blue Medical Recent Development
Table 100. Boston Scientific Corporation Information
Table 101. Boston Scientific Description and Business Overview
Table 102. Boston Scientific Paclitaxel-eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Boston Scientific Paclitaxel-eluting Stent Product
Table 104. Boston Scientific Recent Development
Table 105. DISA Vascular Corporation Information
Table 106. DISA Vascular Description and Business Overview
Table 107. DISA Vascular Paclitaxel-eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. DISA Vascular Paclitaxel-eluting Stent Product
Table 109. DISA Vascular Recent Development
Table 110. Essen Corporation Information
Table 111. Essen Description and Business Overview
Table 112. Essen Paclitaxel-eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Essen Paclitaxel-eluting Stent Product
Table 114. Essen Recent Development
Table 115. Medtronic Vascular Corporation Information
Table 116. Medtronic Vascular Paclitaxel-eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Medtronic Vascular Description and Business Overview
Table 118. Medtronic Vascular Paclitaxel-eluting Stent Product
Table 119. Medtronic Vascular Recent Development
Table 120. MicroPort Medical Corporation Information
Table 121. MicroPort Medical Paclitaxel-eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. MicroPort Medical Description and Business Overview
Table 123. MicroPort Medical Paclitaxel-eluting Stent Product
Table 124. MicroPort Medical Recent Development
Table 125. Terumo Medical Corporation Information
Table 126. Terumo Medical Description and Business Overview
Table 127. Terumo Medical Paclitaxel-eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Terumo Medical Paclitaxel-eluting Stent Product
Table 129. Terumo Medical Recent Development
Table . Orbusneich Corporation Information
Table . Orbusneich Description and Business Overview
Table . Orbusneich Paclitaxel-eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Orbusneich Paclitaxel-eluting Stent Product
Table . Orbusneich Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Paclitaxel-eluting Stent Distributors List
Table 138. Paclitaxel-eluting Stent Customers List
Table 139. Market Key Trends
Table 140. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 141. Key Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Paclitaxel-eluting Stent Product Picture
Figure 2. Global Paclitaxel-eluting Stent Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Paclitaxel-eluting Stent Market Share by Application in 2020 & 2026
Figure 6. Coronary Heart Disease Examples
Figure 7. Clinical Examples
Figure 8. Others Examples
Figure 9. Global Paclitaxel-eluting Stent Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Paclitaxel-eluting Stent Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Paclitaxel-eluting Stent Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Paclitaxel-eluting Stent Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Paclitaxel-eluting Stent Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Paclitaxel-eluting Stent Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Paclitaxel-eluting Stent Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Paclitaxel-eluting Stent Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Paclitaxel-eluting Stent Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Paclitaxel-eluting Stent Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Paclitaxel-eluting Stent Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Paclitaxel-eluting Stent Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Paclitaxel-eluting Stent Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Paclitaxel-eluting Stent Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Paclitaxel-eluting Stent Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Paclitaxel-eluting Stent Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Paclitaxel-eluting Stent Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Paclitaxel-eluting Stent Players Market Share by Revenue in Paclitaxel-eluting Stent 2015 & 2019
Figure 27. Paclitaxel-eluting Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Paclitaxel-eluting Stent Revenue Share by Type (2015-2020)
Figure 29. Global Paclitaxel-eluting Stent Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Paclitaxel-eluting Stent Revenue Share by Application (2015-2020)
Figure 31. Global Paclitaxel-eluting Stent Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Paclitaxel-eluting Stent Sales Market Share by Type in 2019
Figure 33. United States Paclitaxel-eluting Stent Sales Market Share by Type in 2019
Figure 34. Europe Paclitaxel-eluting Stent Sales Market Share by Company in 2019
Figure 35. Europe Paclitaxel-eluting Stent Sales Market Share by Type in 2019
Figure 36. Europe Paclitaxel-eluting Stent Sales Market Share by Application in 2019
Figure 37. China Paclitaxel-eluting Stent Sales Market Share by Company in 2019
Figure 38. China Paclitaxel-eluting Stent Sales Market Share by Type in 2019
Figure 39. China Paclitaxel-eluting Stent Sales Market Share by Application in 2019
Figure 40. Japan Paclitaxel-eluting Stent Sales Market Share by Company in 2019
Figure 41. Japan Paclitaxel-eluting Stent Sales Market Share by Type in 2019
Figure 42. Japan Paclitaxel-eluting Stent Sales Market Share by Application in 2019
Figure 43. Southeast Asia Paclitaxel-eluting Stent Sales Market Share by Company in 2019
Figure 44. Southeast Asia Paclitaxel-eluting Stent Sales Market Share by Type in 2019
Figure 45. Southeast Asia Paclitaxel-eluting Stent Sales Market Share by Application in 2019
Figure 46. India Paclitaxel-eluting Stent Sales Market Share by Company in 2019
Figure 47. India Paclitaxel-eluting Stent Sales Market Share by Type in 2019
Figure 48. India Paclitaxel-eluting Stent Sales Market Share by Application in 2019
Figure 49. B.Braun Melsengen AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Biosensors Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Biotronik Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Blue Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Boston Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. DISA Vascular Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Essen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Medtronic Vascular Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. MicroPort Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Terumo Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Orbusneich Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Key Raw Materials Price Trend
Figure 61. Manufacturing Cost Structure of Paclitaxel-eluting Stent
Figure 62. Manufacturing Process Analysis of Paclitaxel-eluting Stent
Figure 63. Paclitaxel-eluting Stent Industrial Chain Analysis
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 66. Porter's Five Forces Analysis
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
心血管ステントの世界市場レポート2020 A recently published report by QY Research titled Global Cardiovascular Stent Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accura…- 人工心臓ステントの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Artificial Heart Stent market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
- 眼用ステントの世界市場レポート2020 A recently published report by QY Research titled Global Eye Stent Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in …
- 腹部大動脈ステントグラフトシステム（AAAステントグラフトシステム）の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Abdominal Aortic Stent Graft System (AAA Stent Graft System) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx milli…
- 胸部大動脈ステントグラフトシステム（TAAステントグラフトシステム）の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Thoracic Aortic Stent Graft System (TAA Stent Graft System) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx millio…